Clinical Trial Update: CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

View source ↗

Summary

This AstraZeneca-sponsored clinical trial assesses chemo-radiation therapy patterns and short-term outcomes in routine practice for unresectable locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III) | Status: RECRUITING